Coverage
-
September 17, 2018
A New Jersey federal judge has refused to toss claims in a hedge fund group's lawsuit accusing Valeant Pharmaceuticals International Inc. of duping investors about the sustainability of its business model, ruling on Friday that the claim wasn't filed too late under federal securities law.
1 other articles on this case.
View all »